These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1822 related items for PubMed ID: 32845025

  • 1. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R, Lai MC, Beswick A, Gorman DA, Anagnostou E, Szatmari P, Anderson KK, Ameis SH.
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N, Deckx L, van Driel ML.
    Cochrane Database Syst Rev; 2017 Nov 21; 11(11):CD011144. PubMed ID: 29159857
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis.
    Patra S, Nebhinani N, Viswanathan A, Kirubakaran R.
    Autism Res; 2019 Apr 21; 12(4):542-552. PubMed ID: 30653855
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF, Menezes de Padua CA, Golder S, Junqueira DR.
    Cochrane Database Syst Rev; 2021 Jan 18; 1(1):CD013011. PubMed ID: 33460048
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of pharmacological interventions for managing ADHD symptoms in individuals with autism spectrum disorder: A systematic review and meta-analysis.
    Martins PLB, Torquato GCP, Dias GAPF, Leite IB, Gaspar TM, Pinto JP, Macedo DS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug 30; 134():111089. PubMed ID: 39004333
    [Abstract] [Full Text] [Related]

  • 10. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Boesen K, Paludan-Müller AS, Gøtzsche PC, Jørgensen KJ.
    Cochrane Database Syst Rev; 2022 Feb 24; 2(2):CD012857. PubMed ID: 35201607
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M, Munda B, Svab V, Locatelli I.
    J Affect Disord; 2015 Jun 01; 178():149-59. PubMed ID: 25813457
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
    Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, Nagy P, Sonuga-Barke E, Wong IC, Zuddas A, Rosenthal E, Buitelaar JK, ADDUCE consortium.
    CNS Drugs; 2017 Mar 01; 31(3):199-215. PubMed ID: 28236285
    [Abstract] [Full Text] [Related]

  • 13. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X, Blanco-Silvente L, Cunill R.
    Cochrane Database Syst Rev; 2018 Aug 09; 8(8):CD007813. PubMed ID: 30091808
    [Abstract] [Full Text] [Related]

  • 14. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY, Pan YL, Lin HY, Huang LW, Gau SS.
    J Child Adolesc Psychopharmacol; 2015 Sep 09; 25(7):566-73. PubMed ID: 26222447
    [Abstract] [Full Text] [Related]

  • 15. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T, Patsopoulos NA, Weiser M.
    Cochrane Database Syst Rev; 2014 Sep 18; (9):CD005041. PubMed ID: 25230710
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
    Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, Hsieh SC, Bai Z, Hossain A, Skidmore B, Tsakonas E, Chojecki D, Mamdani M, Wells GA.
    PLoS One; 2020 Sep 18; 15(10):e0240584. PubMed ID: 33085721
    [Abstract] [Full Text] [Related]

  • 17. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
    Joshi G, Wilens T, Firmin ES, Hoskova B, Biederman J.
    J Psychopharmacol; 2021 Mar 18; 35(3):203-210. PubMed ID: 33349107
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    Chan E, Fogler JM, Hammerness PG.
    JAMA; 2016 May 10; 315(18):1997-2008. PubMed ID: 27163988
    [Abstract] [Full Text] [Related]

  • 19. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Otasowie J, Castells X, Ehimare UP, Smith CH.
    Cochrane Database Syst Rev; 2014 Sep 19; 2014(9):CD006997. PubMed ID: 25238582
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
    Liu Q, Zhang H, Fang Q, Qin L.
    J Clin Exp Neuropsychol; 2017 Nov 19; 39(9):854-865. PubMed ID: 28052720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.